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Background: A key area-of-need in motor neuron disease/amyotrophic lateral sclerosis (MND/ALS) 
translational research is a tool to objectively track disease progression over short timescales, to 
reduce duration and cost of clinical trials. Previous studies have focused on the central nervous 
system. 
 
Objective: To assess the utility of whole-body MRI to quantify muscle denervation longitudinally in 
patients with MND, as a novel biomarker, and to probe pathophysiological mechanisms in vivo. 
 
Patients and Methods / Material and Methods: In a prospective longitudinal observational cohort 
study, 29 MND patients and 22 age and sex-matched controls were assessed with clinical measures, 
electrophysiological motor unit number index (MUNIX) and T2-weighted whole-body muscle MRI, at 
first presentation to our clinic and four months later. Between-group differences and associations 
were assessed using multivariable regression models, adjusted for age and gender. Within-subject 
longitudinal changes were assessed using paired t-tests. Patterns of disease spread were modeled 
using mixed effects multivariable regression, assessing associations between muscle relative T2 
signal and anatomical adjacency to site of clinical onset. 
 
Results: MND patients had higher relative T2 muscle signal than healthy volunteers at baseline (all-
regions mean + 30%(95%CI 15-45) p < 0.001), that was associated with greater disability on patient-
reported scales (-0.009(-0.001,-0.02),p = 0.023), and greater weakness and lower MUNIX in multiple 
individual muscles. Relative T2 signal in bilateral tibialis anterior increased over four months in 
patients (Figure) (right:+10.2%(2.0-18.4),p = 0.017; left:+14.1%(3.4-24.9),p = 0.013). Anatomically 
contiguous disease spread on MRI was not demonstrated. 
 
Conclusion: Whole-body muscle MRI offers a new approach to the objective assessment of 
denervation and spread in MND in vivo. Muscles inaccessible to conventional clinical and 
neurophysiological assessment may be investigated. 
